Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma by Ka Hey Agnes Fong, Isaac Ho, Tsz Him So

Subjects: “…melanoma…”
Get full text

Epidemiological Profile of Patients with Cutaneous Melanoma in a Region of Southern Brazil by Marcelo Moreno, Ricardo Ludwig Schmitt, Maria Gabriela Lang, Vanessa Gheno

“…Cutaneous melanoma (CM) is responsible for 75% of deaths from malignant skin cancer. …”
Get full text

Coexisting Malignant Melanoma and Blue Nevus of the Uterine Cervix: An Unusual Combination by David Parada, Karla B. Peña, Frances Riu

“…Malignant melanoma (MM) and blue nevi of the uterine cervix are an extremely rare neoplasm, probably derived from embryologic migration of melanocytes from the neural crest. …”
Get full text

Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma by Farhan Ashraf, Fady Marmoush, Muhammad Ismail Shafi, Ashish Shah

Get full text

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients by Mélanie Saint-Jean, Anne-Chantal Knol, Christelle Volteau, Gaëlle Quéreux, Lucie Peuvrel, Anabelle Brocard, Marie-Christine Pandolfino, Soraya Saiagh, Jean-Michel Nguyen, Christophe Bedane, Nicole Basset-Seguin, Amir Khammari, Brigitte Dréno

“…Immunotherapy for melanoma includes adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs). …”
Get full text

The Experience of Melanoma Follow-Up Care: An Online Survey of Patients in Australia by Janine Mitchell, Peta Callaghan, Jackie Street, Susan Neuhaus, Taryn Bessen

“…Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Australia would assist in evaluating if this care is effective and meeting patients’ needs. …”
Get full text

Metastatic Malignant Melanoma of the Inguinal Lymph Node with Unknown Primary Lesion by Sherif Ali Eltawansy, Ryane Panasiti, Samaa Hasanien, Dennis Lourdusamy, David Sharon

“…Around 90% of melanomas have cutaneous origin, but still there are melanomas that could be found in visceral organs or lymph nodes with unknown primary site. …”
Get full text

Saphenous Vein Sparing Superficial Inguinal Dissection in Lower Extremity Melanoma by Muhammed Beşir Öztürk, Arzu Akan, Özay Özkaya, Onur Egemen, Ali Rıza Öreroğlu, Turgut Kayadibi, Mithat Akan

“…The classic inguinal lymph node dissection is the main step for the regional control of the lower extremity melanoma, but this surgical procedure is associated with significant postoperative morbidity. …”
Get full text

Melanoma cutáneo con metástasis gástrica. Presentación de un caso by Jordi Alonso Soto, Teresita Pérez González, Juan González Cansino

Subjects: “…melanoma…”
Get full text

e-Health Tools for Targeting and Improving Melanoma Screening: A Review by Abhilasha Tyagi, Kimberly Miller, Myles Cockburn

“…The key to improved prognosis for melanoma is early detection and diagnosis, achieved by skin surveillance and secondary prevention (screening). …”
Get full text

Micromelanomas: A Review of Melanomas ≤2 mm and a Case Report by Sharad P. Paul

“…The ABCD acronym used to screen pigmented lesions for melanoma obviously was not designed to contend with melanomas that are under 2 mm in diameter. …”
Get full text

Primary Malignant Melanoma of the Gallbladder: A Case Report and Review of the Literature by Mehmet Fatih Haskaraca, Mustafa Ozsoy, İsmail Özsan, Kamile Kurt

“…Malignant melanoma is characterized by the ability of diffuse metastases. …”
Get full text

Primary Malignant Melanoma of the Genitourinary Tract with Upper and Lower Tracts Involvement by Broderick Sutton, Robert Chan, Mark Sutton, Timothy Boone

“…Biopsy of these lesions revealed malignant melanoma invading the lamina propria. No dermatologic lesions were identified suggesting a primary malignant melanoma of the genitourinary system.…”
Get full text

A Review of the Aetiopathogenesis and Clinical and Histopathological Features of Oral Mucosal Melanoma by Liviu Feller, Razia A. G. Khammissa, Johan Lemmer

“…Oral mucosal melanoma is an uncommon, usually heavily melanin-pigmented, but occasionally amelanotic aggressive tumour with a poor prognosis. …”
Get full text

Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma by Ugur Uslu, Franz Heppt, Michael Erdmann

“…Thus, biopsy or surgical excision of the skin alteration may be necessary to rule out melanoma.…”
Get full text

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV by Diwakar Davar, Melissa Wilson, Chelsea Pruckner, John M. Kirkwood

“…On the basis of remarkable antitumor activity, programmed death receptor-1 (PD-1) inhibitors pembrolizumab and nivolumab were approved for the treatment of advanced melanoma in the second-line setting following progression on either CTLA-4 inhibitor ipilimumab or BRAF/MEK inhibitors (for BRAF mutated melanoma). …”
Get full text

Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre by Vera Teixeira, Ricardo Vieira, Inês Coutinho, Rita Cabral, David Serra, Maria José Julião, Maria Manuel Brites, Anabela Albuquerque, João Pedroso de Lima, Américo Figueiredo

“…Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cutaneous melanoma. The National Comprehensive Cancer Network (NCCN) Melanoma Panel has reinforced the status of the sentinel lymph node (SLN) as an important prognostic factor for melanoma survival. …”
Get full text

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells by Hidehito Saito, Keisuke Okita, Noemi Fusaki, Michael S. Sabel, Alfred E. Chang, Fumito Ito

“…Tumor-infiltrating lymphocytes (TILs) that express programmed cell death protein-1 (PD-1) are tumor-reactive T cells, and adoptive cell therapy with autologous TILs has been found to achieve durable complete response in selected patients with metastatic melanoma. Here, we describe the derivation of human iPSCs from melanoma TILs expressing high level of PD-1 by Sendai virus-mediated transduction of the four transcription factors, OCT3/4, SOX2, KLF4, and c-MYC. …”
Get full text

Aggressive Behaviour of Metastatic Melanoma in a Patient with Neurofibromatosis Type 1 by Robert W. Foley, Robert M. Maweni, Aurelie Fabre, David G. Healy

“…Malignant melanoma is a common skin neoplasm bearing poor prognosis when presenting with metastases. …”
Get full text

Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma by Jeremy Chuang, An Uche, Rohan Gupta, Kim Margolin, Phyllis Kim

“…In this case report, we discuss a 33-year-old woman with BRAF V600E-mutated metastatic melanoma who presented in fulminant DIC with concurrent hemorrhagic and thrombotic manifestations and discuss the patient’s brief response to combination therapy. …”
Get full text